Value-Added Nanotechnology
Pioneer company of nanohybrids for industrial applications
Bridge between labs, clinical trials, and industry, we ensure innovation reaches its full potential
Nano-H, founded in December 2004 by Lyon university researchers, specializes in developing innovative technologies for new materials based on hybrid nanoparticles. The company focuses on functional nanomaterials for optics and tracers, nanomaterials for biological applications, particularly nanodrugs, and chitosan-based hydrogels for biomedical use. Additionally, Nano-H leverages AI to analyze multimineral profiles for innovative diagnostic and prognostic purposes.
Nano-H developed the first hybrid organic/inorganic theranostic drug, AGuIX
Competences
Nano-H bridges the gap between lab discoveries and real-world applications. By connecting research, pre-clinical and clinical trials, and industry expertise, it turns scientific breakthroughs into practical, market-ready solutions.
Develoment of nanoparticles with scalable production, tailored for optics, medical imaging, diagnostics, and pharmaceuticals
Nano-H offers fast, affordable, and high-quality preclinical trials on mice and rats to accelerate your research.
Nano-H combines expertise in chemistry and AI to offer advanced data analysis, visualization, and predictive modeling, solving simple or complex cases.
Each year, Nano-H organizes a conference on nanotechnology and biochemistry, set in the stunning locations of Corsica or Porquerolles, bringing together experts to exchange ideas and drive innovation.
At Nano-H, we specialize in developing high-performance hybrid nanoparticles with scalable production capabilities, from milligrams to kilograms. Through advanced synthesis, functionalization, and purification, we deliver custom inorganic particles with rigorous quality control, tailored for applications in optics, medical imaging, diagnostics, and pharmaceuticals.
Synthesis
Functionalization
Characterization
Purification
Through its collaboration with the top-notch startup I2V, Nano-H offers unparalleled preclinical trials on mice and rats, characterized by favorable pricing and fast turnaround times, ensuring swift progress in your research endeavors."
Toxicity studies (drug candidates, bioimaging agents, pesticides etc.) on mice and rats
Efficacy studies, oral, parenteral or topical route of administration, single or multiple dosing:
Methods : Hematological analysis, Biochemical analysis, Histopathology,
ICP-MS...
Statistical an AI Analyses
Nano-H has recently developed expertise in data analysis, data visualization, and predictive results using machine learning and AI. Our unique combination of chemistry and computer science expertise allows us to tackle complex cases where a standard AI expert might fall short.
Data visualisation
Prediction with Machine learning
Mineral Profile
Our team
Meet the people who keep our projects moving forward.
Augustin Tillement - CEO
Engineer
Olivier Tillement - cofounder
professeur - Université Claude Bernard Lyon 1
Stéphane Roux- cofounder
professeur - Institut UTINAM
Pascal Perriat - cofounder
professeur
Guillaume Jacquot
Phd Student - ICANS
Perrine Schneller
Phd Student - CRANS
Established industry leadership
We’re proud to collaborate with a network of leading industries, universities, and hospitals. These partnerships allow us to leverage diverse expertise, accelerate innovation, and bring solutions to the table. Below are some of the valued partners who share our vision and support our mission.
Contributions to Science
Nano-H bridges the gap between lab discoveries and real-world applications. By connecting research, pre-clinical and clinical trials, and industry expertise, it turns scientific breakthroughs into practical, market-ready solutions.
Over the years, our team has contributed to more than 200 publications. These works underscore our commitment to advancing knowledge, sharing insights, and shaping the future of our field.
Nano-H has collaborated with numerous companies and academic laboratories on collaborative projects, participating in 17 ANR, European, or other projects as a co-developer or contractor.
Patents
Nano-H has played a key role in filing over 15 patents, including three since 2023. These patents represent the tangible results of our innovative research and our ongoing commitment to turning cutting-edge ideas into valuable intellectual property.
New patents : FR2110474, EP23306075
Adress
305 Rue des Fours
Fontaines Saint Martin
69270
Contact
+33 6 13 16 58 97